Evaluation of Rapid Virological Response in HCV [hepatitis C virus] Patients Treated With PegIntron and Ribavirin - APEGIN Trial.
Phase of Trial: Phase III
Latest Information Update: 03 Jun 2014
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms APEGIN
- Sponsors Schering-Plough
- 16 Dec 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 16 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Aug 2009 Planned end date changed from Jul 2009 to Oct 2009 as reported by ClinicalTrials.gov.